Latest Asx News

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Toubani Resources has initiated a 5,000-metre diamond drilling campaign at its Kobada Gold Project in Mali, targeting deeper mineralisation to expand its 2.2 million ounce resource and extend mine life.

Gibb River Diamonds has successfully completed a heritage survey over the proposed open pit at its Neta Prospect, removing a key obstacle to mining development within the Edjudina Gold Project. The project moves closer to production with mining costs borne by a private contractor.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

IRIS Metals has reported promising high-grade lithium intersections from its Phase I drilling at the Edison Project in South Dakota, reinforcing its strategy to develop a centralized lithium processing hub in the US.

Rox Resources has initiated dewatering at the Youanmi Gold Project’s Main and United North pits, marking a critical step toward underground access and production. The company is on track with exploration declines and resource updates, progressing steadily toward gold production.

Black Canyon Limited has initiated a 3,000-metre reverse circulation drilling program at its Wandanya Project, aiming to expand on promising high-grade manganese and iron mineralisation along 1.5km of a 3km strike. The program is supported by a WA Government co-funded grant, with assay results expected in the coming months.

Pacgold Limited reports strong initial results from its 2025 drilling campaign at the Alice River Gold Project, revealing significant shallow high-grade gold intersections that reinforce the project’s bulk tonnage and high-grade potential.

Locate Technologies Limited has raised $316,500 by issuing 2.4 million shares to Novus Capital under its At-the-Market Facility, aiming to bolster its balance sheet amid ongoing growth in last-mile delivery technology.

Galileo Mining reports promising palladium and platinum assay results from aircore drilling at its Norseman project, reinforcing potential for new discoveries along the Mission Sill trend. Follow-up drilling is planned to expand on these encouraging findings.

Amplia Therapeutics has reported a rare pathological complete response in a patient from its ACCENT trial, highlighting promising potential for its drug narmafotinib in treating advanced pancreatic cancer.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.